EMcision and the CTS

EMcision develops a radio-frequency technology for the surgical community. The Habib™4X, which treats liver cancer, is n°1 in the hepatic resection devices in United-States.

 

With this success the company can currently commercialize and develop new devices to improve care provided to the patient by radio-frequency.

« Our products give, for the first time, a non invasive access for the clinicians to the digestive system's deep organs to apply radio-frequencies treatments. With the CTS Santé's help we keep up more effectively our objective which is to improve therapeutic devices to beat biliary tract and pancreas cancers. »

François PoulinGeneral Director, EMcision International

Project images